Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States (vol 22, pg 408, 2019)

Minckwitz Von

首页> 外文期刊>Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research >Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States (vol 22, pg 408, 2019)

【24h】

Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States (vol 22, pg 408, 2019)

机译：成本效益分析的Pertuzumab曲妥珠单抗和化疗相比曲妥珠单抗和化疗的辅助治疗her2阳性乳腺癌的美国(22卷,408 pg, 2019)

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research 》 |2019年第7期| 843-843| 共1页
作者
Minckwitz Von;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类
关键词
adjuvant therapy; Antineoplastic Agents; United StatesDrug TherapyCost-Effectiveness AnalysisHerceptinpertuzumab;

机译：辅助治疗,抗肿瘤药制剂;团结StatesDrug TherapyCost-EffectivenessAnalysisHerceptinpertuzumab;

相似文献

外文文献
中文文献

Cost-Effectiveness Analysis of Pertuzumab With Trastuzumab and Chemotherapy Compared to Trastuzumab and Chemotherapy in the Adjuvant Treatment of HER2-Positive Breast Cancer in the United States (vol 22, pg 408, 2019)

著录项

相似文献

相关主题

期刊订阅